Source: Equities

Accurexa: Accurexa Files Patent Application for its ACX-31 Brain Cancer Program

NEWARK, DE / ACCESSWIRE / July 7, 2016 / Accurexa Inc. (the "Company") (OTCQB: ACXA), a biotechnology company focused on the development of novel neurological therapies to be directly delivered into the brain, announced today that it filed a new patent app

Read full article »
Annual Revenue
$5.0-25M
Employees
1-25
George Yu's photo - President & CEO of Accurexa

President & CEO

George Yu

CEO Approval Rating

70/100